These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 590850)

  • 1. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
    Weston MJ; Langley PG; Rubin MH; Hanid MA; Mellon P; Williams R
    Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biocompatibility of coated and uncoated charcoal during haemoperfusion in healthy dogs.
    Weston MJ; Hanid A; Rubin MH; Langley PG; Mellon PJ; Williams R
    Eur J Clin Invest; 1977 Oct; 7(5):401-6. PubMed ID: 411670
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin to prevent platelet activation during charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Langley PG; Hughes RD; Canalese J; Mellon PJ; Williams R; Woods HF; Weston MJ
    Lancet; 1980 Jan; 1(8161):173-5. PubMed ID: 6101632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet function during haemoperfusion in acute liver failure.
    Hughes RD; Lane DA; Cella G; Kakkar VV; Langley PG; Williams R
    Int J Artif Organs; 1980 Jan; 3(1):30-4. PubMed ID: 6444397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Earlier charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
    Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-vitro blood compatibility studies on a new polymer-coated charcoal for haemoperfusion.
    Hughes RD; Langley PG; Williams R
    Int J Artif Organs; 1980 Sep; 3(5):277-9. PubMed ID: 7461861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adhesiveness to glass beads in liver disease.
    Langley PG; Hughes RD; Williams R
    Acta Haematol; 1982; 67(2):124-7. PubMed ID: 6801894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum octopamine, coma, and charcoal haemoperfusion in fulminant hepatic failure.
    Chase RA; Trewby PN; Davis M; Williams R
    Eur J Clin Invest; 1977 Oct; 7(5):351-4. PubMed ID: 411665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin eliminates the bioincompatibility of charcoal haemoperfusion.
    Weston MJ; Woods HF; Bunting S; Moncada S; Vane JR
    Proc Eur Dial Transplant Assoc; 1979; 16():225-31. PubMed ID: 398492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Disorders of blood coagulatiion during haemoperfusion (author's transl)].
    Niessner H; Pichler M
    Wien Klin Wochenschr; 1977 May; 89(10):347-50. PubMed ID: 68628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of haemoperfusion through charcoal or XAD-2 resin on an animal model of fulminant liver failure.
    Weston MJ; Gazzard BG; Buxton BH; Winch J; Machado AL; Flax H; Williams R
    Gut; 1974 Jun; 15(6):482-6. PubMed ID: 4851751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Charcoal haemoperfusion in the treatment of fulminant hepatic failure.
    Gazzard BG; Weston MJ; Murray-Lyon IM; Flax H; Record CO; Williams R; Portmann B; Langley PG; Dunlop EH; Mellon PJ; Ward MB
    Lancet; 1974 Jun; 1(7870):1301-7. PubMed ID: 4134293
    [No Abstract]   [Full Text] [Related]  

  • 14. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure.
    Seda HW; Hughes RD; Gove CD; Williams R
    Artif Organs; 1984 May; 8(2):174-8. PubMed ID: 6329147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of haemoperfusion on haemostasis and cellular constituents of the blood in the treatment of intoxications: a comparative study of three types of columns (Haemocol, Amberlite XAD-4, Gambro Adsorba 300 C).
    Sangster B; van Heijst AN; Sixma JJ
    Arch Toxicol; 1981 Jul; 47(4):269-78. PubMed ID: 7271453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostacyclin eliminates the thrombocytopenia associated with charcoal hemoperfusion and minimizes heparin and fibrinogen consumption.
    Woods HF; Weston MJ; Bunting S; Moncada S; Vane J
    Artif Organs; 1980 Aug; 4(3):176-9. PubMed ID: 6998437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 9 beta-methylcarbacyclin, a stable prostacyclin analogue, in prevention of platelet losses during charcoal haemoperfusion.
    Hughes RD; Langley PG; Guarner F; Williams R
    J Pharm Pharmacol; 1986 Jan; 38(1):63-5. PubMed ID: 2869131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated charcoal haemoperfusion via an extracorporeal circuit in the unrestrained and unanaesthetized rat.
    Ryan CJ; Courtney JM; Wood CB; Hood RG; Blumgart LH
    Br J Exp Pathol; 1979 Aug; 60(4):400-10. PubMed ID: 508590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo experiments with powder charcoal haemoperfusion (filmadsorber) in a pig model of hepatic failure.
    van Berlo AM; de Groot GH; Schalm SW; Jansen PP; de Vries EH; Fick T; Reuvers C; Boks AL
    Int J Artif Organs; 1985 Nov; 8(6):335-40. PubMed ID: 4077293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with charcoal and resin hemoperfusion.
    Hughes R; Williams R
    Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.